A benz[d]isoxazole compound and application thereof

CN117088864BActive Publication Date: 2026-03-03GUANGZHOU IMD THERAPEUTICS CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202210522716.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-05-13
Publication Date
2026-03-03
Estimated Expiration
2042-05-13

Smart Images

  • Figure CN117088864B_ABST
    Figure CN117088864B_ABST
Patent Text Reader

Abstract

The application provides a benzene [d] isoxazole compound and an application thereof. The compound has the structure shown in the following formula I. The benzene [d] isoxazole compound provided by the application can induce degradation of BET protein and / or GSPT1 protein, and has an anti-proliferation effect on cancer cells. Therefore, the compound and the composition provided by the application can be used for preparing a drug for treating or preventing tumor formation, inflammation, viral infection, cell proliferative disorder, autoimmune disease, sepsis and the like.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • BET protein degraders

    CN109311890A

  • Fused 1,4-oxazepines as bet protein degraders

    CN110062759A

  • Compositions and methods of use of 2-(4-chlorophenyl)-n-((2-(2,6-doxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl) -2,2-difluoroacetamide

    CN111032043A

  • Amide compound having bet proteolysis-inducing action and medicinal application thereof

    CN112543764A

  • Benzo[d]isoxazole compound and application thereof

    CN105085427A